News Vir Biotechnology Announces New Clinical Data From its Broad Hepatitis B Program Continue Reading Previous Arbutus Presents New Data on AB-729, AB-836 and AB-101 at the EASL International Liver Congress™ 2022 and Provides AB-836 Clinical UpdateNext Madrigal Pharmaceuticals Presents Late-Breaking Phase 3 NASH Data and Multiple Oral Abstracts at EASL’s International Liver Congress™ Related Stories News PageUp Expands in UK Market; Appoints Industry Veteran Chris Chesterman to Lead Global Revenue Growth News Telefónica Germany Migrates 4G/5G Voice Services of First 100K Customers to Mavenir Cloud-Native IMS Technology News LeoList Launches AI-Powered Anti-Fraud Measures to Strengthen Platform Safety News California Dealer Academy Expands California Dealer License Training for Used Car, Wholesale, and Auto Broker Applicants News Shenglong Electric’s AI Distribution Cabinet Debuts at Frankfurt OPTATEC News Qoder Version 1.0 Released: Full Automation of Code Generation, Verification & Delivery
